LifeStance director reports RSU tax share withholding

LifeStance Health Group director Kenneth A. Burdick reported a tax-related share withholding tied to vested restricted stock units.

Accepted by SEC EDGAR 03/09/2026 - 08:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group director Kenneth A. Burdick reported a tax-related share withholding tied to vested restricted stock units. On March 6, 2026, the issuer withheld 424,551 shares of common stock at $7.11 per share to cover tax obligations, which the filing states is not an open-market sale. After this net settlement, Burdick directly holds 3,012,020 shares and indirectly holds 46,511 shares through Burdick Family LLC.

Insider Trade Summary

Exercise Price or Tax Liability: 424,551 shares

Exercise Price or Tax Liability 1 txn

Insider Burdick Kenneth A

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	424,551	$7.11	$3.02M
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,012,020 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (1)

1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LifeStance (LFST) report for Kenneth A. Burdick?

Kenneth A. Burdick reported a tax-related share withholding. On March 6, 2026, 424,551 LifeStance common shares were withheld to satisfy tax obligations from vested RSUs, which the filing clarifies did not involve any open-market sale of shares.

How many LifeStance (LFST) shares were withheld for Kenneth Burdick’s RSU taxes?

The issuer withheld 424,551 common shares from Kenneth Burdick on March 6, 2026. These shares covered tax withholding on vested restricted stock units and reduced the net shares issued, without constituting an open-market sale according to the filing footnote.

At what price were the withheld LifeStance (LFST) shares valued in Burdick’s Form 4?

The withheld shares were valued at $7.11 per share. This price applied to 424,551 common shares retained by the issuer to satisfy tax withholding obligations related to Kenneth Burdick’s RSU vesting on March 6, 2026.

How many LifeStance (LFST) shares does Kenneth Burdick own after the Form 4 transaction?

Kenneth Burdick directly owns 3,012,020 LifeStance shares following the tax withholding transaction. He also has indirect ownership of 46,511 additional shares held through Burdick Family LLC, as disclosed in the Form 4 filing.

Was Kenneth Burdick’s LifeStance (LFST) Form 4 an open-market stock sale?

No, the Form 4 does not report an open-market sale. The filing explains that 424,551 shares were withheld by the issuer solely to satisfy tax withholding obligations on vested RSUs, rather than sold in the open market.

What indirect LifeStance (LFST) holdings does Kenneth Burdick report?

Burdick reports 46,511 LifeStance shares as indirect holdings. These shares are held through Burdick Family LLC, with the Form 4 designating this position as indirect ownership separate from his directly held common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		F(1)		424,551	D	$7.11	3,012,020	D
Common Stock								46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

	By: /s/ Ryan Pardo, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.